Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 29.18B | 28.51B | 24.49B | 20.42B | 17.19B | 15.20B |
Gross Profit | 18.54B | 17.90B | 15.42B | 12.57B | 11.01B | 9.88B |
EBITDA | 9.66B | 10.70B | 9.94B | 9.17B | 7.55B | 6.26B |
Net Income | 5.46B | 6.29B | 5.95B | 5.29B | 4.29B | 3.33B |
Balance Sheet | ||||||
Total Assets | 57.18B | 57.18B | 54.98B | 50.11B | 42.69B | 39.29B |
Cash, Cash Equivalents and Short-Term Investments | 17.49B | 21.66B | 25.43B | 22.73B | 18.89B | 17.18B |
Total Debt | 76.00M | 83.00M | 58.00M | 117.00M | 128.00M | 62.48M |
Total Liabilities | 4.52B | 4.85B | 5.15B | 4.70B | 3.49B | 2.72B |
Stockholders Equity | 52.67B | 52.33B | 49.83B | 45.41B | 39.20B | 36.57B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 129.00M | 4.31B | 4.62B | 2.52B | 248.97M |
Operating Cash Flow | 0.00 | 7.81B | 8.03B | 6.56B | 6.38B | 1.94B |
Investing Cash Flow | 0.00 | -6.64B | -4.02B | -2.17B | -3.44B | -38.33M |
Financing Cash Flow | 0.00 | -3.70B | -3.25B | -2.44B | -2.23B | -2.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $192.21B | 23.53 | 6.38% | 3.12% | 2.72% | -6.31% | |
75 Outperform | €179.19B | 34.68 | 4.39% | 2.53% | 10.98% | -76.45% | |
73 Outperform | ¥147.83B | 28.60 | ― | 2.60% | 5.10% | -17.80% | |
69 Neutral | €91.59B | 18.85 | 6.01% | 2.29% | 3.13% | 2.91% | |
68 Neutral | ¥69.08B | 16.74 | ― | 2.72% | 6.82% | -1.08% | |
66 Neutral | $628.13B | 49.29 | 8.67% | 1.00% | 11.60% | -19.38% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |